The viewpoint of the committee and the algorithm developed are, in many ways, very similar to the article previously published by this author on this topic. [3] The current commentary will review the ...
SEATTLE -- Risk of death was lower in the years after a bisphosphonate was started following a fracture rather than denosumab (Prolia), a target trial emulation found. In adults ages 50 and older who ...
May 13, 2011— -- Many doctors are changing the prescribing length of a class of osteoporosis medication known as bisphosphonates after mounting evidence has linked long-term use of the medication ...
This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component.
Clinical outcomes and epidemiology of acute ischemic stroke in breast cancer patients admitted to U.S. hospital. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...
Bisphosphonates have long been established as critical agents in the treatment of bone disorders, yet recent innovations in their green synthesis are paving the way for more sustainable, efficient, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback